- Home
- GROW vs KALA Comparison
GROW vs KALA Comparison
Compare GROW & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- KALA
- Stock Information
- Founded
- GROW 1968
- KALA 2009
- Country
- GROW United States
- KALA United States
- Employees
- GROW N/A
- KALA N/A
- Industry
- GROW Investment Managers
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- KALA Health Care
- Exchange
- GROW Nasdaq
- KALA Nasdaq
- Market Cap
- GROW 31.8M
- KALA 26.2M
- IPO Year
- GROW N/A
- KALA 2017
- Fundamental
- Price
- GROW $2.46
- KALA $5.70
- Analyst Decision
- GROW
- KALA Strong Buy
- Analyst Count
- GROW 0
- KALA 3
- Target Price
- GROW N/A
- KALA $14.00
- AVG Volume (30 Days)
- GROW 42.1K
- KALA 137.8K
- Earning Date
- GROW 09-09-2025
- KALA 08-05-2025
- Dividend Yield
- GROW 3.64%
- KALA N/A
- EPS Growth
- GROW N/A
- KALA N/A
- EPS
- GROW 0.01
- KALA N/A
- Revenue
- GROW $8,932,000.00
- KALA N/A
- Revenue This Year
- GROW N/A
- KALA N/A
- Revenue Next Year
- GROW N/A
- KALA N/A
- P/E Ratio
- GROW $234.30
- KALA N/A
- Revenue Growth
- GROW N/A
- KALA N/A
- 52 Week Low
- GROW $2.02
- KALA $2.92
- 52 Week High
- GROW $2.73
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- GROW 56.26
- KALA 59.39
- Support Level
- GROW $2.35
- KALA $5.39
- Resistance Level
- GROW $2.58
- KALA $6.30
- Average True Range (ATR)
- GROW 0.09
- KALA 0.63
- MACD
- GROW -0.01
- KALA 0.03
- Stochastic Oscillator
- GROW 36.36
- KALA 56.00
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.